Shareholders’ equity (Tables)

3 Months Ended

Mar. 31, 2026

Stockholders' Equity Note [Abstract]

Schedule of stock based compensation expense

The table below summarizes information about the Company’s stock-based compensation for the three months ended March 31, 2026 and 2025 and the expense recognized in the condensed consolidated statements of operations:

	Three Months Ended March 31,
	2026		2025
Stock options
Options granted during period	952,400		3,943,722
Weighted average exercise price	$	4.39	$	3.31
Restricted stock units (RSUs)
Restricted stock units granted during period	371,500		901,900
Grant date fair value	$	4.39	$	3.29
	Three Months Ended March 31,
	2026		2025
	(in thousands)
Stock compensation expense
Research and development	$	416	$	555
General and administrative	906		738
Total stock compensation expense	$	1,322	$	1,293